Structured telephone support or telemonitoring programs for patients with chronic heart failureLevosimendan vs. dobutamine: outcomes for acute heart failure patients on beta-blockers in SURVIVEEuropean Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm SocietyClinical trials update from the European Society of Cardiology-Heart Failure meeting 2015: AUGMENT-HF, TITRATION, STOP-HF, HARMONIZE, LION HEART, MOOD-HF, and renin-angiotensin inhibitors in patients with heart and renal failureAssessment and prevalence of pulmonary oedema in contemporary acute heart failure trials: a systematic reviewGeographic differences in heart failure trialsHeart failure as a general pandemic in AsiaUpdated meta-analysis on antithrombotic therapy in patients with heart failure and sinus rhythmUric acid and risk of heart failure: a systematic review and meta-analysisA contemporary view on endothelial function in heart failureTargeting anti-beta-1-adrenergic receptor antibodies for dilated cardiomyopathyCardiac resynchronization therapy in heart failure patients with less severe left ventricular dysfunctionUse of implantable cardioverter defibrillators in patients with left ventricular assist devicesThe kidney in congestive heart failure: 'are natriuresis, sodium, and diuretics really the good, the bad and the ugly?'The emerging issue of cardiac dysfunction induced by antineoplastic angiogenesis inhibitorsHeart failure and socioeconomic status: accumulating evidence of inequalityShould antidiabetic treatment of type 2 diabetes in patients with heart failure differ from that in patients without?Targeting myocardial remodelling to develop novel therapies for heart failure: a position paper from the Working Group on Myocardial Function of the European Society of CardiologyNeprilysin inhibition to treat heart failure: a tale of science, serendipity, and second chancesState of the Art: Newer biomarkers in heart failureTargeting myocardial substrate metabolism in heart failure: potential for new therapiesAgents with vasodilator properties in acute heart failure: how to design successful trialsIron therapy for the treatment of iron deficiency in chronic heart failure: intravenous or oral?Non-compliance and knowledge of prescribed medication in elderly patients with heart failureEnhanced levels of CD154 (CD40 ligand) on platelets in patients with chronic heart failureClinical trials update from the European Society of Cardiology: CHARM, BASEL, EUROPA and ESTEEMPharmacological treatment in patients with heart failure: patients knowledge and occurrence of polypharmacy, alternative medicine and immunizationsAspirin, ACE inhibitors and arterial stiffnessClinical trials update and cumulative meta-analyses from the American College of Cardiology: WATCH, SCD-HeFT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO-Lipids and cardiac resynchronisation therapy in heart failureAspirin does not influence the effect of angiotensin-converting enzyme inhibition on left ventricular ejection fraction 3 months after acute myocardial infarctionAdverse mortality effect of central sympathetic inhibition with sustained-release moxonidine in patients with heart failure (MOXCON)Clinical trials update from the American College of Cardiology meeting: CARE-HF and the remission of heart failure, Women's Health Study, TNT, COMPASS-HF, VERITAS, CANPAP, PEECH and PREMIERClinical trials update: highlights of the scientific sessions of the XXIII Congress of the European Society of Cardiology--WARIS II, ESCAMI, PAFAC, RITZ-1 and TIMEClinical trials update from the European Society of Cardiology meeting 2005: CARE-HF extension study, ESSENTIAL, CIBIS-III, S-ICD, ISSUE-2, STRIDE-2, SOFA, IMAGINE, PREAMI, SIRIUS-II and ACTIVEWhole blood impedance aggregometry for the assessment of platelet function in patients with congestive heart failure (EPCOT Trial)The effect of carvedilol in patients with impaired left ventricular systolic function following an acute myocardial infarction. How do the treatment effects on total mortality and recurrent myocardial infarction in CAPRICORN compare with previous beAntithrombotic therapy is associated with better survival in patients with severe heart failure and left ventricular systolic dysfunction (EPICAL study)The importance of anemia and its correction in the management of severe congestive heart failurePatterns of pharmacotherapy in patients hospitalised for congestive heart failureAspirin alters arterial function in patients with chronic heart failure treated with ACE inhibitors: a dose-mediated deleterious effect
P1433
Q24242621-5D03DE9A-FEAF-4051-AB49-D91CE34FE07DQ24650903-244A30BE-C6EF-477E-863B-CA6CEB23C846Q26796261-C47C702E-1093-4A35-B770-EE931460BC17Q26796378-2268C8B0-FC12-4380-B378-74BB1A230E1BQ26800965-39E5B17B-9307-4724-99DF-7DCAD2E6F1B2Q26801222-DE53C88D-E384-40B7-8412-FB09C50FEB7AQ26801810-1B8A4C13-144E-4C49-88F8-1E1039339115Q26822837-73A5DE54-F676-4492-9CCC-456333C4085BQ26852555-DBFB32CB-540C-44B5-90C2-DA1083C8FBEEQ26865866-4644C909-8BB2-484A-B90F-C413871C185EQ27000434-69E646F0-6AEA-42FA-B6E4-8688EAD92D80Q27002918-BD0AA6BC-065B-4690-AB68-F7D1CCB1E0E6Q27009542-608A68DE-F591-4645-8FAD-7023D3747766Q27011043-F10D6C32-2CDC-4AED-A0EF-B486E1BE2520Q27011540-CC925CDA-0281-44C0-A87D-EFFF730AADE6Q27012972-F36F4876-7443-4D89-8A61-8A96C4C5C5E9Q27022813-73454EE3-D245-4977-9B83-D01B80BF3E90Q27024879-38AD1747-359B-426F-9C38-39555FB54ECBQ27027707-ACAFC88E-AD6E-4294-A375-D6DE3DA92CB1Q27027899-7A0374C7-015A-4B8A-B757-2616BF2DB59EQ27694733-4B699F64-AB53-4F8F-BD1F-D1B7C95B43EAQ28084239-0EA5A432-1F8E-4D82-895A-4C02634B8C87Q28088503-69BDB3BE-27B0-4026-B2AF-5B31B7241B97Q28143264-A229B04D-3104-4ACC-A283-330BAA3F27C8Q28166019-71139701-454F-46A9-8888-160391D55477Q28166022-0DD3A91A-D184-40F1-8C3C-C3EAA45D18F6Q28167451-526DAC68-A9BF-4190-BEF8-995321B4913BQ28167690-420599E4-E1C8-4318-B274-6AB343E2897EQ28168872-D1EF3AA5-1048-4CE6-B569-7230FB070688Q28176936-0B058026-9EEF-4C32-ACFA-CE5918E1A9E7Q28182735-B54ADB53-4281-4122-8443-55FC99460028Q28186417-745484A9-8C50-4C95-A2DC-E5DDD8DF8953Q28191847-A955C071-F8E4-4C85-8524-72FF6BCB9F03Q28192714-57161E6D-5612-45B6-8C7A-39146896B377Q28193563-84CC44ED-96A5-4583-82AC-7A19753ABBB3Q28193565-8E9A0C8D-5176-46E2-8FB1-9476AD5FA2BFQ28194101-AA3B8C52-DF85-431A-BCCD-486357690634Q28194293-A01CB5BB-A8FD-4A6A-855F-9B9FCFEE1435Q28195422-C2D03009-E65D-4F80-8934-85573802FD79Q28196412-D6BEFC80-2654-47A0-BDF2-5B0432F26055
P1433
description
begutachtete wissenschaftliche Zeitschrift
@de
peer-reviewed journal of the H ...... European Society of Cardiology
@en
revista científica
@es
rivista scientifica
@it
vědecký časopis
@cs
wetenschappelijk tijdschrift van Elsevier
@nl
वैज्ञानिक पत्रिका
@hi
name
European Journal of Heart Failure
@ast
European Journal of Heart Failure
@da
European Journal of Heart Failure
@de
European Journal of Heart Failure
@en
European Journal of Heart Failure
@es
European Journal of Heart Failure
@fi
European Journal of Heart Failure
@fr
European Journal of Heart Failure
@it
European Journal of Heart Failure
@nb
European Journal of Heart Failure
@nl
type
label
European Journal of Heart Failure
@ast
European Journal of Heart Failure
@da
European Journal of Heart Failure
@de
European Journal of Heart Failure
@en
European Journal of Heart Failure
@es
European Journal of Heart Failure
@fi
European Journal of Heart Failure
@fr
European Journal of Heart Failure
@it
European Journal of Heart Failure
@nb
European Journal of Heart Failure
@nl
prefLabel
European Journal of Heart Failure
@ast
European Journal of Heart Failure
@da
European Journal of Heart Failure
@de
European Journal of Heart Failure
@en
European Journal of Heart Failure
@es
European Journal of Heart Failure
@fi
European Journal of Heart Failure
@fr
European Journal of Heart Failure
@it
European Journal of Heart Failure
@nb
European Journal of Heart Failure
@nl
P31
P3181
P356
P4616
P1055
P1058
P1156
P123
P1277
P1476
European Journal of Heart Failure
@en
P236
P3181
P356
10.1002/(ISSN)1879-0844
P407
P495
P571
1999-01-01T00:00:00Z